Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia

go back to reference Assaraf YG, Brozovic A, Gonçalves AC, Jurkovicova D, Linē A, Machuqueiro M, Saponara S, Sarmento-Ribeiro AB, Xavier CPR, Vasconcelos MH (2019) The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resist Updat 46:100645CrossRefPubMed Assaraf YG, Brozovic A, Gonçalves AC, Jurkovicova D, Linē A, Machuqueiro M, Saponara S, Sarmento-Ribeiro AB, Xavier CPR, Vasconcelos MH (2019) The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resist Updat 46:100645CrossRefPubMed

go back to reference Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pagès F, Speicher MR, Trajanoski Z, Galon J (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39:782–795CrossRefPubMed Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pagès F, Speicher MR, Trajanoski Z, Galon J (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39:782–795CrossRefPubMed

go back to reference Cheng Z, Dai Y, Pang Y, Jiao Y, Liu Y, Cui L, Quan L, Qian T, Zeng T, Si C, Huang W, Chen J, Pang Y, Ye X, Shi J, Fu L (2020) Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia. J Cell Mol Med 24:1067–1075CrossRefPubMed Cheng Z, Dai Y, Pang Y, Jiao Y, Liu Y, Cui L, Quan L, Qian T, Zeng T, Si C, Huang W, Chen J, Pang Y, Ye X, Shi J, Fu L (2020) Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia. J Cell Mol Med 24:1067–1075CrossRefPubMed

go back to reference Colwill K, Gräslund S (2011) A roadmap to generate renewable protein binders to the human proteome. Nat Methods 8:551–558CrossRefPubMed Colwill K, Gräslund S (2011) A roadmap to generate renewable protein binders to the human proteome. Nat Methods 8:551–558CrossRefPubMed

go back to reference Döhner H, Weisdorf DJ, Bloomfield CD (2015) Acute myeloid Leukemia. N Engl J Med 373:1136–1152CrossRefPubMed Döhner H, Weisdorf DJ, Bloomfield CD (2015) Acute myeloid Leukemia. N Engl J Med 373:1136–1152CrossRefPubMed

go back to reference Gwak JM, Jang MH, Kim DI, Seo AN, Park SY (2015) Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer. PLoS ONE 10:e0125728CrossRefPubMedPubMedCentral Gwak JM, Jang MH, Kim DI, Seo AN, Park SY (2015) Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer. PLoS ONE 10:e0125728CrossRefPubMedPubMedCentral

go back to reference Hänzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7CrossRefPubMedPubMedCentral Hänzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7CrossRefPubMedPubMedCentral

go back to reference Ip WE, Hoshi N, Shouval DS, Snapper S, Medzhitov R (2017) Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356:513–519CrossRefPubMedPubMedCentral Ip WE, Hoshi N, Shouval DS, Snapper S, Medzhitov R (2017) Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356:513–519CrossRefPubMedPubMedCentral

go back to reference Kantarjian HM, Short NJ, Fathi AT, Marcucci G, Ravandi F, Tallman M, Wang ES, Wei AH (2021) Acute myeloid leukemia: historical perspective and progress in research and therapy over 5 decades. Clin Lymphoma Myeloma Leuk 21:580–597CrossRefPubMed Kantarjian HM, Short NJ, Fathi AT, Marcucci G, Ravandi F, Tallman M, Wang ES, Wei AH (2021) Acute myeloid leukemia: historical perspective and progress in research and therapy over 5 decades. Clin Lymphoma Myeloma Leuk 21:580–597CrossRefPubMed

go back to reference Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, Hoadley K, Triche TJ, Laird PW, Baty JD, Fulton LL, Fulton R, Heath SE, Kalicki-Veizer J, Kandoth C, Klco JM, Koboldt DC, Kanchi KL, Kulkarni S, Lamprecht TL, Larson DE, Lin L, Lu C, Mclellan MD, Mcmichael JF, Payton J, Schmidt H, Spencer DH, Tomasson MH, Wallis JW, Wartman LD, Watson MA, Welch J, Wendl MC, Ally A, Balasundaram M, Birol I, Butterfield Y, Chiu R, Chu A, Chuah E, Chun HJ, Corbett R, Dhalla N, Guin R, He A, Hirst C, Hirst M, Holt RA, Jones S, Karsan A, Lee D, Li HI, Marra MA, Mayo M, Moore RA, Mungall K, Parker J, Pleasance E, Plettner P, Schein J, Stoll D, Swanson L, Tam A, Thiessen N, Varhol R, Wye N, Zhao Y, Gabriel S, Getz G, Sougnez C, Zou L, Leiserson MD, Vandin F, Wu HT, Applebaum F, Baylin SB, Akbani R, Broom BM, Chen K, Motter TC, Nguyen K, Weinstein JN, Zhang N, Ferguson ML, Adams C, Black A, Bowen J, Gastier-Foster J, Grossman T, Lichtenberg T, Wise L, Davidsen T, Demchok JA, Shaw KR, Sheth M, Sofia HJ, Yang L, Downing JR, Eley G (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368:2059–74CrossRefPubMed Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, Hoadley K, Triche TJ, Laird PW, Baty JD, Fulton LL, Fulton R, Heath SE, Kalicki-Veizer J, Kandoth C, Klco JM, Koboldt DC, Kanchi KL, Kulkarni S, Lamprecht TL, Larson DE, Lin L, Lu C, Mclellan MD, Mcmichael JF, Payton J, Schmidt H, Spencer DH, Tomasson MH, Wallis JW, Wartman LD, Watson MA, Welch J, Wendl MC, Ally A, Balasundaram M, Birol I, Butterfield Y, Chiu R, Chu A, Chuah E, Chun HJ, Corbett R, Dhalla N, Guin R, He A, Hirst C, Hirst M, Holt RA, Jones S, Karsan A, Lee D, Li HI, Marra MA, Mayo M, Moore RA, Mungall K, Parker J, Pleasance E, Plettner P, Schein J, Stoll D, Swanson L, Tam A, Thiessen N, Varhol R, Wye N, Zhao Y, Gabriel S, Getz G, Sougnez C, Zou L, Leiserson MD, Vandin F, Wu HT, Applebaum F, Baylin SB, Akbani R, Broom BM, Chen K, Motter TC, Nguyen K, Weinstein JN, Zhang N, Ferguson ML, Adams C, Black A, Bowen J, Gastier-Foster J, Grossman T, Lichtenberg T, Wise L, Davidsen T, Demchok JA, Shaw KR, Sheth M, Sofia HJ, Yang L, Downing JR, Eley G (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368:2059–74CrossRefPubMed

go back to reference Liu C, Li Y, Wei M, Zhao L, Yu Y, Li G (2019) Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma. Cell Cycle 18:568–579CrossRefPubMedPubMedCentral Liu C, Li Y, Wei M, Zhao L, Yu Y, Li G (2019) Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma. Cell Cycle 18:568–579CrossRefPubMedPubMedCentral

go back to reference National Cancer Institute. Cancer stat facts: leukemia—acute myeloid leukemia (AML).https://seer.cancer.gov/statfacts/html/amyl.html. https://seer.cancer.gov/statfacts/html/amyl.html. 2021. Cancer Stat Facts: Leukemia—Acute Myeloid Leukemia (AML). https://seer.cancer.gov/statfacts/html/amyl.htmlhttps://seer.cancer.gov/statfacts/html/amyl.html. Accessed 21 Sep 2017. National Cancer Institute. Cancer stat facts: leukemia—acute myeloid leukemia (AML).https://​seer.​cancer.​gov/​statfacts/​html/​amyl.​html. https://​seer.​cancer.​gov/​statfacts/​html/​amyl.​html. 2021. Cancer Stat Facts: Leukemia—Acute Myeloid Leukemia (AML). https://​seer.​cancer.​gov/​statfacts/​html/​amyl.​htmlhttps://​seer.​cancer.​gov/​statfacts/​html/​amyl.​html. Accessed 21 Sep 2017.

go back to reference Nguyen CH, Glüxam T, Schlerka A, Bauer K, Grandits AM, Hackl H, Dovey O, Zöchbauer-Müller S, Cooper JL, Vassiliou GS, Stoiber D, Wieser R, Heller G (2019) SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness. Sci Rep 9:9139CrossRefPubMedPubMedCentral Nguyen CH, Glüxam T, Schlerka A, Bauer K, Grandits AM, Hackl H, Dovey O, Zöchbauer-Müller S, Cooper JL, Vassiliou GS, Stoiber D, Wieser R, Heller G (2019) SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness. Sci Rep 9:9139CrossRefPubMedPubMedCentral

go back to reference Pinno J, Bongartz H, Klepsch O, Wundrack N, Poli V, Schaper F, Dittrich A (2016) Interleukin-6 influences stress-signalling by reducing the expression of the mTOR-inhibitor REDD1 in a STAT3-dependent manner. Cell Signal 28:907–916CrossRefPubMed Pinno J, Bongartz H, Klepsch O, Wundrack N, Poli V, Schaper F, Dittrich A (2016) Interleukin-6 influences stress-signalling by reducing the expression of the mTOR-inhibitor REDD1 in a STAT3-dependent manner. Cell Signal 28:907–916CrossRefPubMed

go back to reference Pinto JA, Rolfo C, Raez LE, Prado A, Araujo JM, Bravo L, Fajardo W, Morante ZD, Aguilar A, Neciosup SP, Mas LA, Bretel D, Balko JM, Gomez HL (2017) In silico evaluation of DNA damage inducible transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies. Sci Rep 7:1526CrossRefPubMedPubMedCentral Pinto JA, Rolfo C, Raez LE, Prado A, Araujo JM, Bravo L, Fajardo W, Morante ZD, Aguilar A, Neciosup SP, Mas LA, Bretel D, Balko JM, Gomez HL (2017) In silico evaluation of DNA damage inducible transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies. Sci Rep 7:1526CrossRefPubMedPubMedCentral

go back to reference Porta C, Paglino C, Mosca A (2014) Targeting PI3K/Akt/mTOR Signaling in cancer. Front Oncol 4:64CrossRefPubMedPubMedCentral Porta C, Paglino C, Mosca A (2014) Targeting PI3K/Akt/mTOR Signaling in cancer. Front Oncol 4:64CrossRefPubMedPubMedCentral

go back to reference Reville PK, Kadia TM (2020) Maintenance therapy in AML. Front Oncol 10:619085CrossRefPubMed Reville PK, Kadia TM (2020) Maintenance therapy in AML. Front Oncol 10:619085CrossRefPubMed

go back to reference Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504CrossRefPubMedPubMedCentral Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504CrossRefPubMedPubMedCentral

go back to reference Shimony S, Stahl M, Stone RM (2023) Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 98:502–526CrossRefPubMed Shimony S, Stahl M, Stone RM (2023) Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 98:502–526CrossRefPubMed

go back to reference Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S, Budanov A, Chajut A, Kalinski H, Kamer I, Rozen A, Mor O, Keshet E, Leshkowitz D, Einat P, Skaliter R, Feinstein E (2002) Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 22:2283–2293CrossRefPubMedPubMedCentral Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S, Budanov A, Chajut A, Kalinski H, Kamer I, Rozen A, Mor O, Keshet E, Leshkowitz D, Einat P, Skaliter R, Feinstein E (2002) Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 22:2283–2293CrossRefPubMedPubMedCentral

go back to reference Small S, Oh TS, Platanias LC (2022) Role of biomarkers in the management of acute myeloid leukemia. Int J Mol Sci 23:14543CrossRefPubMedPubMedCentral Small S, Oh TS, Platanias LC (2022) Role of biomarkers in the management of acute myeloid leukemia. Int J Mol Sci 23:14543CrossRefPubMedPubMedCentral

go back to reference Sofer A, Lei K, Johannessen CM, Ellisen LW (2005) Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 25:5834–5845CrossRefPubMedPubMedCentral Sofer A, Lei K, Johannessen CM, Ellisen LW (2005) Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 25:5834–5845CrossRefPubMedPubMedCentral

go back to reference Stanchina M, Soong D, Zheng-Lin B, Watts JM, Taylor J (2020) Advances in acute myeloid leukemia: recently approved therapies and drugs in development. Cancers 12:3225CrossRefPubMedPubMedCentral Stanchina M, Soong D, Zheng-Lin B, Watts JM, Taylor J (2020) Advances in acute myeloid leukemia: recently approved therapies and drugs in development. Cancers 12:3225CrossRefPubMedPubMedCentral

go back to reference Ustun C, Miller JS, Munn DH, Weisdorf DJ, Blazar BR (2011) Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation? Blood 118:5084–5095CrossRefPubMedPubMedCentral Ustun C, Miller JS, Munn DH, Weisdorf DJ, Blazar BR (2011) Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation? Blood 118:5084–5095CrossRefPubMedPubMedCentral

go back to reference Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, Pfeil J, Narkizian J, Deran AD, Musselman-Brown A, Schmidt H, Amstutz P, Craft B, Goldman M, Rosenbloom K, Cline M, O’connor B, Hanna M, Birger C, Kent WJ, Patterson DA, Joseph AD, Zhu J, Zaranek S, Getz G, Haussler D, Paten B (2017) Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol 35:314–316CrossRefPubMedPubMedCentral Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, Pfeil J, Narkizian J, Deran AD, Musselman-Brown A, Schmidt H, Amstutz P, Craft B, Goldman M, Rosenbloom K, Cline M, O’connor B, Hanna M, Birger C, Kent WJ, Patterson DA, Joseph AD, Zhu J, Zaranek S, Getz G, Haussler D, Paten B (2017) Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol 35:314–316CrossRefPubMedPubMedCentral

go back to reference Wang M, Zhang C, Tian T, Zhang T, Wang R, Han F, Zhong C, Hua M, Ma D (2018) Increased regulatory T cells in peripheral blood of acute myeloid leukemia patients rely on tumor necrosis factor (TNF)-α-TNF receptor-2 pathway. Front Immunol 9:1274CrossRefPubMedPubMedCentral Wang M, Zhang C, Tian T, Zhang T, Wang R, Han F, Zhong C, Hua M, Ma D (2018) Increased regulatory T cells in peripheral blood of acute myeloid leukemia patients rely on tumor necrosis factor (TNF)-α-TNF receptor-2 pathway. Front Immunol 9:1274CrossRefPubMedPubMedCentral

go back to reference Zhao X, Li Y, Wu H (2018) A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes. Int J Mol Med 42:1495–1507PubMedPubMedCentral Zhao X, Li Y, Wu H (2018) A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes. Int J Mol Med 42:1495–1507PubMedPubMedCentral